Form D · Biotechnology
MED DEV Corp
Sterling, VA · CIK 0001554290
Offering snapshot reported Jul 17, 2013 · SEC filing
- Reported sold
- $775K Offering amount: $3M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 8, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 10
- Minimum accepted$50,000 → $25,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 17, 2013 | Amendment | $775,000 | No comparison | 10 | SEC filing |
| Jun 4, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-197440
Source: Form D, filed Jul 17, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas J. Finley | Director, Executive |
| Michael G. Martin | Director, Executive |
| Michael F. Moore | Director, Executive |
| William P. Peters | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
47648 Mid Surrey Square
Sterling, VA, 20165
Sterling, VA, 20165